Monitoring drug safety with registries: useful components of postmarketing pharmacovigilance systems

Cameron Willis, John McNeil, Peter Cameron, Louise Phillips

Research output: Contribution to journalComment / DebateResearchpeer-review

19 Citations (Scopus)

Abstract

At the time of licensing by regulatory agencies, the full range of risks and possible adverse drug reactions associated with a medication is rarely fully realized. This commentary aims to describe the role of registries as useful components of postmarketing pharmacovigilance systems for monitoring highly specialized medications associated with significant financial costs.
Original languageEnglish
Pages (from-to)121 - 125
Number of pages5
JournalJournal of Clinical Epidemiology
Volume65
Issue number2
DOIs
Publication statusPublished - 2012

Cite this